يعرض 1 - 10 نتائج من 14 نتيجة بحث عن '"Enfermedades del Nervio Óptico"', وقت الاستعلام: 0.86s تنقيح النتائج
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    المساهمون: Ortíz Salas, Paola Andrea

    المصدر: Papais-Alvarenga RM, Vasconcelos CCF, Carra A, De Castillo IS, Florentin S, De Bedoya FHD, et al. Central nervous system idiopathic inflammatory demyelinating disorders in South Americans: A descriptive, multicenter, cross-sectional study. PLoS One. 2015; 10(7): e0127757. doi:10.1371/journal.pone.0127757
    Etemadifar M, Nasr Z, Khalili B, Taherioun M, Vosoughi R. Epidemiology of Neuromyelitis Optica in the World: A Systematic Review and Meta-Analysis. Mult Scler Int. 2015; Volume 2015, Article ID 174720, 8 pages http://dx.doi.org/10.1155/2015/174720
    De Carvalho Jennings Pereira WL, Reiche EMV, Kallaur AP, Kaimen-Maciel DR. Epidemiological, clinical, and immunological characteristics of neuromyelitis optica: A review. Journal of the Neurological Sciences. 2015. 7–17 Contents http://dx.doi.org/10.1016/j.jns.2015.05.034
    Jarius S, Wildemann B, Paul F. Neuromyelitis optica: Clinical features, immunopathogenesis and treatment. Clin Exp Immunol. 2014; 176: 149–164. doi:10.1111/cei.12271
    Reyes MA, Viviana Á, Granados N, Ramírez SF. Trabajo original Espectro de neuromielitis óptica en Colombia, primera caracterización clínico imagenológica en tres centros de Bogotá Spectrum of optic neuromyelitis in colombia, first characterization clinical and radiological in three centers of Bogotá. Acta Neurológica Cololmbiana 2016;32(3):190–202.
    Dutra BG, da Rocha AJ, Nunes RH, Maia ACM. Neuromyelitis Optica Spectrum Disorders: Spectrum of MR Imaging Findings and Their Differential Diagnosis. RadioGraphics. 2018; 38:169–193 doi.org/10.1148/rg.2018170141
    Bruscolini A, Sacchetti M, La Cava M, Gharbiya M, Ralli M, Lambiase A, et al. Diagnosis and management of neuromyelitis optica spectrum disorders-An update. Autoimmunity Reviews 17 (2018) 195–200 Contents. doi.org/10.1016/j.autrev.2018.01.001
    Mealy MA, Wingerchuk DM, Greenberg BM, Levy M. Epidemiology of neuromyelitis optica in the United States: A multicenter analysis. Arch Neurol. 2012; 69 (9): 1176-1180 DOI: 10.1001/archneurol.2012.314
    Hor JY, Lim TT, Chia YK, Ching YM, Cheah CF, Tan K, et al. Prevalence of neuromyelitis optica spectrum disorder in the multi-ethnic Penang Island, Malaysia, and a review of worldwide prevalence. Mult Scler Relat Disord. 2018 Jan;19:20-24. doi: 10.1016/j.msard.2017.10.015.
    Weinshenker BG, Wingerchuk DM. Neuromyelitis Spectrum Disorders. Mayo Clinic Proceedings. 2017. Mayo Clin Proc. 2017 Apr;92(4):663-679. doi: 10.1016/j.mayocp.2016.12.014.
    Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, et al. VIEWS & REVIEWS International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. 2015. Neurology. 2016 Feb 2;86(5):491-2. doi: 10.1212/WNL.0000000000002366.
    Jacob A, McKeon A, Nakashima I, Sato DK, Elsone L, Fujihara K, et al. Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders. Journal of Neurology, 2013 Aug;84(8):922-30. doi: 10.1136/jnnp-2012-302310.
    andit L, Asgari N, Apiwattanakul M, Palace J, Paul F, Leite MI, et al. Demographic and clinical features of neuromyelitis optica: A review. Mult Scler. 2015 Jun;21(7):845-53. doi: 10.1177/1352458515572406.
    Drori T, Chapman J. Diagnosis and classification of neuromyelitis optica (Devic’s Syndrome). Autoimmun Rev. 2014 Apr-May;13(4-5):531-3. doi: 10.1016/j.autrev.2014.01.034.
    Trebst C, Jarius S, Berthele A, Paul F, Schippling S, Wildemann B, et al. Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS). Journal of the Neurological Sciences 355 (2015) 7–17. DOI: 10.1016/j.jns.2015.05.034
    Patterson SL, Goglin SE. Neuromyelitis Optica. 2017. Rheum Dis Clin North Am. 2017 Nov;43(4):579-591. doi: 10.1016/j.rdc.2017.06.007.
    Marignier R, Calvo AC, Vukusic S. Neuromyelitis optica and neuromyelitis optica spectrum disorders. Curr Opin Neurol. 2017 Jun;30(3):208-215. doi: 10.1097/WCO.0000000000000455.
    Asgari N. Epidemiological, clinical and immunological aspects of neuromyelitis optica (NMO). Dan Med J. 2013 Oct;60(10):B4730. PMID 24083534
    Rivera JF, Kurtzke JF, Booth VJA, Corona V T. Characteristics of Devic’s disease (neuromyelitis optica) in Mexico. J Neurol. 2008;255(5):710–5. May;255(5):710-5. doi: 10.1007/s00415-008-0781-2.
    Sahraian MA, Radue EW, Minagar A. Neuromyelitis Optica. Clinical Manifestations and Neuroimaging Features. Neurologic Clinics. 2013. Neurol Clin. 2013 Feb;31(1):139-52. doi: 10.1016/j.ncl.2012.09.010.
    Misra MK, Damotte V, Hollenbach JA. The immunogenetics of neurological disease. Immunology. 2018. Apr;153(4):399-414. doi: 10.1111/imm.12869.
    Kim HJ, Paul F, Lana-Peixoto MA, Tenembaum S, Asgari N, Palace J, et al. MRI characteristics of neuromyelitis optica spectrum disorder: An international update. Neurology. 2015;84(11):1165–73. Mar 17;84(11):1165-73. doi: 10.1212/WNL.0000000000001367
    Matthews LA, Palace JA. The role of imaging in diagnosing neuromyelitis optica spectrum disorder. Multiple Sclerosis and Related Disorders. 2014. 2014
    Kremer S, Renard F, Achard S, Lana-Peixoto MA, Palace J, Asgari N, et al. Use of advanced magnetic resonance imaging techniques in neuromyelitis optica spectrum disorder. JAMA Neurology. 2015. Jul;72(7):815-22. doi: 10.1001/jamaneurol.2015.0248.
    Sellner J, Boggild M, Clanet M, Hintzen RQ, Illes Z, Montalban X, et al. EFNS guidelines on diagnosis and management of neuromyelitis optica. Eur J Neurol. 2010;17(8):1019–32. Aug;1 Aug;17(8):1019-32. doi: 10.1111/j.1468-1331.2010.03066.x 7(8):1019-32.
    S.Jarius, K.Ruprecht, B.Wildemann, T. Kuempfel, M.Ringelstein, C.Geis, et al. Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients. J Neuroinflammation. 2012;9:14. Jan 19;9:14. doi: 10.1186/1742-2094-9-14
    Collongues N, Marignier R, Jacob A, Leite MI, Siva A, Paul F, et al. Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset. Mult Scler J. 2014; Jul;20(8):1086-94. doi: 10.1177/1352458513515085
    Kremer L, Mealy M, Jacob A, Nakashima I, Cabre P, Bigi S, et al. Brainstem manifestations in neuromyelitis optica: A multicenter study of 258 patients. Mult Scler J. 2014;20(7):843–7 doi: 10.1177/1352458513507822.
    Seok JM, Cho HJ, Ahn SW, Cho E Bin, Park MS, Joo IS, et al. Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea. Mult Scler J. 2017; Nov;23(13):1748-1756. doi: 10.1177/1352458516685416.
    Repositorio EdocUR-U. Rosario
    Universidad del Rosario
    instacron:Universidad del Rosario

    وصف الملف: application/pdf

  7. 7
  8. 8
  9. 9
  10. 10
    مورد إلكتروني

    عناروين إضافية: Ophthalmologic repercussions of obstructive sleep apnea-hypopnea syndrome (OSAHS)

    المصدر: Revista de la Facultad de Medicina; Vol. 65, Núm. 1Sup (2017); 59-63; 2357-3848; 0120-0011

    URL: https://revistas.unal.edu.co/index.php/revfacmed/article/view/59567/61277
    https://revistas.unal.edu.co/index.php/revfacmed/article/view/59567/61278
    https://revistas.unal.edu.co/index.php/revfacmed/article/downloadSuppFile/59567/21074
    https://revistas.unal.edu.co/index.php/revfacmed/article/view/59567/61277
    https://revistas.unal.edu.co/index.php/revfacmed/article/view/59567/61278
    https://revistas.unal.edu.co/index.php/revfacmed/article/downloadSuppFile/59567/21074
    *ref*/Abdal H, Pizzimenti JJ, Purvis CC. The eye in sleep apnea syndrome. Sleep Med. 2006;7(2):107-15. http://doi.org/b6vzpk.
    *ref*/Nieto-Enríquez J, Torres-Blanch J, Badal-Lafulla J. Manifestaciones oculares del síndrome de apnea del sueño. Med Clin (Barc). 2009;133(15):594-8. http://doi.org/fmvv6p.
    *ref*/McNab AA. The eye and sleep apnea. Sleep Med Rev. 2007;11(4):269-76. http://doi.org/d6dgcb.
    *ref*/McNab AA. Floppy eyelid syndrome and obstructive sleep apnea. Ophtahl Plast Reconstr Surg. 1997;13(2):98-114. http://doi.org/br978f.
    *ref*/Karger RA, Whute WA, Park WC, Rosales AG, McLaren JW, Olson EJ, et al. Prevalence of floppy eyelid syndrome in obstructive sleep apnea-hypoapnea syndrome. Ophthalmology. 2006;113(9):1669-74. http://doi.org/dxxmts.
    *ref*/Culberston WW, Ostler HB. The floppy eye syndrome. Am J Ophthalmol. 1981;92(4):568-75.
    *ref*/Mojon DS, Goldblum D, Fleischhauer J, Chiou AG, Frueh BE, Hess CW, et al. Eyelid conjunctival and corneal findings in sleep apnoea syndrome. Ophthalmology. 1999;106(6):1182-5. http://doi.org/btfgr6.
    *ref*/Waller EA, Bendel RE, Kaplan J. Sleep disorders and the eye. Mayo Clin Proc. 2008;83(11):1251-61. http://doi.org/dhkqb7.
    *ref*/Dhillon S, Shapiro CM, Flanagan J. Sleep disordered breathing and effects on ocular health. Can J Ophthalmol. 2007;42:238-43. http://doi.org/bnnh.
    *ref*/Pepperl JE, Ghuman T, Gill KS, Zieske JD, Trocme SD. Conjunctiva. In: Duane’s Clinical ophthalmolgy. Lippincot Williams & Wilkins. http://goo.gl/xuTSVl.
    *ref*/Chambe J, Laib S, Hubbard J, Erhardt C, Ruppert E, Schroder C, et al. Floppy eyelid syndrome is associated with obstructive sleep apnoea: a prospective study on 127 patients. J Sleep Res. 2012;21(3):308-15. http://doi.org/ctthk4.
    *ref*/Netland PA, Sugrue SP, Albert DM, Shore JW. Histopathologic features of the floppy eyelid syndrome: Involvement of tarsal elastin. Ophthalmology. 1994;101(1):174-81. http://doi.org/bnnj.
    *ref*/Faridi O, Park SC, Liebmann JM, Ritch R. Glaucoma and obstructive apnoea-hipoapnoea syndrome. Clin Experiment Opththalmol. 2012;40(4):408-19. http://doi.org/bnnk.
    *ref*/Bendel RE, Kaplan J, Heckman M, Fredrickson PA, Lin SC. Prevalence of glaucoma in patients with sleep apnoea a cross sectional case series. Eye (Lond). 2008;22(9):1105-09. http://doi.org/fjzss7.
    *ref*/De Vivero C, Ruiz A, Urrea-Victoria T, Hidalgo-Martínez P, Briceño-Montoya M. Prevalencia de glaucoma en pacientes con síndrome de apnea hipoapnea obstructiva del sueño en el hospital San Ignacio, Bogotá. [En prensa].
    *ref*/De Vivero C, Ruíz A, Becerra C. Trabeculectomía una terapia vigente: estudio observacional descriptivo en el Hospital Universitario San Ignacio en Bogotá. Universitas Médica. 2014;55(3):278-85.
    *ref*/Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol. 1996;80(5):389-93. http://doi.org/dwjvw4.
    *ref*/Kiekens S, Groot VD, Coeckelbergh T, Tassignon MJ, van de Heyning P, De Backer W, et al. Continuous positive airway pressure therapy is associated with an increase in intraocular pressure in obstructive sleep apnea. Invest Ophthalmol Vis Sci. 2008;49(3):934-40. http://doi.org/c3679g.
    *ref*/Kadyan A, Asghar J, Dowson L, Sandramouli S. Ocular findings in sleep apnoea patients using continuous positive airway pressure. Eye (Lond). 2010;24(5):843-50. http://doi.org/dwns6t.
    *ref*/Kremmer S, Niederdräing N, Ayertey HD, Steuhl KP, Selbach JM. Obstructive sleep apnoea syndrome, normal tension glaucoma and nCPAP therapy a short note. Sleep. 2003;26(2):161-2.
    *ref*/Biousse V, Newman N. Ischemic Optic Neuropathies. N Engl J Med. 2005;372(25):2428-36. http://doi.org/bnnm.
    *ref*/Arango-Simoni K, Mejía-Echavarría L, Abad-Londoño J. Oftalmología. Fundamentos de cirugía. Medellín: Fondo Editorial CIB; 2013
    *ref*/Behbehani R, Mathews MK, Sergott RC, Savino PJ. Nonarteritic anterior ischemic optic neuropathy in patients with sleep apnea while being treated with continuous positive airway pressure. Am J Ophthalmol. 2005;139(3):518-21. http://doi.org/c2tmtw.
    *ref*/Quinn AG, Gouws P, Headland S, Oades P, Pople I, Taylor D, et al. Obstructive sleep apnea syndrome with bilateral papilledema and vision loss in a 3-year-old child. J AAPOS. 2008;12(2):197-9. http://doi.org/c83bjn.
    *ref*/Mohamed EE, Massoud TH. Effect of sleep related breathing disorders on ocular function. Egypt J Chest Dis Tuberc. 2014;63(3):663-9. http://doi.org/bnnp.
    *ref*/Castaño G. Fisiopatología del Papiledema. Revisión de Tema. Universitas Médica, 1998;39(3):78-84.
    *ref*/Rich GB. Article reviewed: Papilledema and obstructive sleep apnea syndrome. Sleep Med. 2001;2(3):259-61. http://doi.org/b2xhfc.
    *ref*/Álvarez-Sala R, Díaz S, Prados C, Villasante C, Villamor J. Increase of intraocular pressure during nasal CPAP. Chest. 1992;101(5):1477. http://doi.org/b954fx.
    *ref*/Álvarez-Sala R, García IT, García F, Moriche J, Prados C, Díaz S, et al. Nasal CPAP during wakefulness increases intraocular pressure in glaucoma. Monaldi Arch Chest Dis. 1994;49(5):394-5.